Correlation between impulse magnitude and inhibition of cell proliferation in alternating electric fields therapy
Source abstract
Abstract
This study was designed to investigate the correlation between the impulse by dielectrophoretic force applied inside a dividing cell during alternating electric fields therapy and the inhibition of cell proliferation. Distributions of the electric field and dielectrophoretic force inside a dividing cell were calculated using the finite element method of COMSOL Multiphysics. Based on the results, the average magnitude of the impulse by the dielectrophoretic force applied to the cleavage furrow inside a dividing cell placed in various directions was calculated as a function of electric field intensity at an extracellular reference point. The simulation results showed that the average magnitude of the impulse to the cleavage furrow inside a dividing cell ranged from 1.51 × 10−9 to 1.49 × 10−7 N s when tumor treating fields with an intensity ranging from 0.1 to 1 V/cm is applied at an extracellular reference point for 6 h. To verify the relationships between the impulse by the dielectrophoretic force and the inhibition of cell proliferation, the survival fractions of the four cancer cell lines were determined as a function of intensity and time duration of the electric field. The correlation between the magnitude and application time of the electric field and the survival fractions of the four cell lines showed similar trends in vitro. These results suggest that both the dielectrophoretic force and the time required for the force to act are proportionally related to the inhibitory effect on dividing cells, enabling this impulse to be used as a reference to quantify the inhibition of cell proliferation.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Microbial Inactivation Methods · Microfluidic and Bio-sensing Technologies · Planarian Biology and Electrostimulation
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Bioengineering, Korea University 1 , Seoul, Republic of Korea
Department of Radiation Oncology, Inha University School of Medicine 2 , Incheon, Republic of Korea
Institute of Global Health Technology (IGHT), Korea University 3 , Seoul, Republic of Korea
FieldCure Ltd. 4 , Seoul, Republic of Korea
Funding
National Research Foundation of Korea · Korea Medical Device Development Fund
References (30)
Show source-provided references
1. Tumor treating fields: A new Frontier in cancer therapy10.1111/nyas.12112 ↗
2. Mitotic disruption and reduced clonogenicity of pancreatic cancer cells in vitro and in vivo by tumor treating fields10.1016/j.pan.2013.11.009 ↗
3. Tumor treating fields: A novel treatment modality and its use in brain tumors10.1093/neuonc/now182 ↗
4. Tumor treating fields (TTF) treatment enhances radiation-induced apoptosis in pancreatic cancer cells10.1080/09553002.2020.1838658 ↗
5. Sorafenib increases tumor treating fields-induced cell death in glioblastoma by inhibiting STAT3
6. Effect of tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma: A randomized clinical trial10.1001/jama.2017.18718 ↗
7. Tumor-treating fields (TTFields)-based cocktail therapy: A novel blueprint for glioblastoma treatment
8. The combination of tumor treating fields and hyperthermia has synergistic therapeutic effects in glioblastoma cells by downregulating STAT3
9. Advances in radiotherapy and comprehensive treatment of high-grade glioma: Immunotherapy and tumor-treating fields10.7150/jca.51107 ↗
10. Tumor treating fields: At the crossroads between physics and biology for cancer treatment10.3389/fonc.2020.575992 ↗
11. Tumor treating fields: A novel and effective therapy for glioblastoma: Mechanism, efficacy, safety and future perspectives10.21037/cco.2017.06.29 ↗
12. Disruption of cancer cell replication by alternating electric fields10.1158/0008-5472.can-04-0083 ↗
13. An overview of sub-cellular mechanisms involved in the action of TTFields10.3390/ijerph13111128 ↗
14. Tumour-treating fields (TTFields): Investigations on the mechanism of action by electromagnetic exposure of cells in telophase/cytokinesis10.1038/s41598-019-43621-9 ↗
15. Dielectrophoresis of cells10.1016/s0006-3495(71)86249-5 ↗
16. A theoretical study on the biophysical mechanisms by which tumor treating fields affect tumor cells during mitosis10.1109/tbme.2020.2965883 ↗
17. Correlation of tumor treating fields dosimetry to survival outcomes in newly diagnosed glioblastoma: A large-scale numerical simulation-based analysis of data from the phase 3 EF-14 randomized trial10.1016/j.ijrobp.2019.04.008 ↗
18. The impact of tumor treating fields on glioblastoma progression patterns10.1016/j.ijrobp.2021.12.152 ↗
19. Potential prognostic factor in alternating electric fields therapy based on absorbed energy in tissue10.1063/5.0100820 ↗
20. Effectiveness of a fractionated therapy scheme in tumor treating fields therapy10.1177/1533033819845008 ↗
21. 2005
22. B-lines lung ultrasonography simulation using finite element method10.3390/diagnostics12112751 ↗
23. Investigating mechanisms of action of tumor treating fields (TTFieldsTM): A computational modeling study10.1093/neuonc/nou278.15 ↗
24. Modeling Tumor Treating Fields (TTFields) application in single cells during metaphase and telophase
25. An approach to electrical modeling of single and multiple cells10.1073/pnas.0636434100 ↗
26. 1989
27. On a finite-element method for solving the three-dimensional Maxwell equations10.1006/jcph.1993.1214 ↗
28. 1978
29. Dielectrophoresis for bioparticle manipulation10.3390/ijms151018281 ↗
30. Cytokinesis defects and cancer10.1038/s41568-018-0084-6 ↗